Cutaneous histoplasmosis in patients with acquired immunodeficiency syndrome

Cutis. 2003 Dec;72(6):439-45.

Abstract

Since 1987, the US Centers for Disease Control and Prevention has considered disseminated histoplasmosis an acquired immunodeficiency syndrome (AIDS)-defining illness. Cutaneous manifestations of disseminated disease are diverse and often present as a nondescript rash with systemic complaints. Diagnosis is best established by histopathologic examination with appropriate stains for fungal organisms. Skin lesions often resolve within weeks of initiating treatment. We detail a case of cutaneous histoplasmosis and review its epidemiology, common presentations, diagnosis, and treatment options.

Publication types

  • Case Reports

MeSH terms

  • AIDS-Related Opportunistic Infections / diagnosis*
  • AIDS-Related Opportunistic Infections / drug therapy
  • Adult
  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use
  • Diagnosis, Differential
  • Histoplasmosis / diagnosis*
  • Histoplasmosis / drug therapy
  • Humans
  • Itraconazole / therapeutic use
  • Male
  • Skin Diseases / diagnosis*
  • Skin Diseases / drug therapy

Substances

  • Antifungal Agents
  • Itraconazole
  • Amphotericin B